SC 13G | 2023-09-05 | CONTINENTAL GENERAL INSURANCE CO | Paratek Pharmaceuticals, Inc. | 3,693,981 | 6.4% | EDGAR |
SC 13D/A | 2023-06-27 | NexPoint Real Estate Opportunities, LLC | Paratek Pharmaceuticals, Inc. | 50,000 | 0.1% | EDGAR |
SC 13D | 2023-03-30 | NexPoint Real Estate Opportunities, LLC | Paratek Pharmaceuticals, Inc. | 50,000 | 0.1% | EDGAR |
SC 13G/A | 2023-03-20 | HIRSCHMAN ORIN | Paratek Pharmaceuticals, Inc. | 2,802,115 | 4.9% | EDGAR |
SC 13G/A | 2023-02-15 | HIRSCHMAN ORIN | Paratek Pharmaceuticals, Inc. | 4,156,891 | 7.5% | EDGAR |
SC 13G/A | 2023-02-13 | LYTTON LAURENCE W | Paratek Pharmaceuticals, Inc. | 459,961 | 0.8% | EDGAR |
SC 13G/A | 2023-01-20 | NexPoint Real Estate Opportunities, LLC | Paratek Pharmaceuticals, Inc. | 50,000 | 0.1% | EDGAR |
SC 13G | 2022-07-08 | BlackRock Inc. | Paratek Pharmaceuticals, Inc. | 869,224 | 1.6% | EDGAR |
SC 13G/A | 2022-07-07 | HIRSCHMAN ORIN | Paratek Pharmaceuticals, Inc. | 3,887,172 | 7.7% | EDGAR |
SC 13G | 2022-05-18 | LYTTON LAURENCE W | Paratek Pharmaceuticals, Inc. | 3,210,552 | 5.9% | EDGAR |
SC 13G | 2022-03-11 | DONDERO JAMES D | Paratek Pharmaceuticals, Inc. | 50,000 | 0.0% | EDGAR |
SC 13G | 2022-03-09 | HIRSCHMAN ORIN | Paratek Pharmaceuticals, Inc. | 2,820,067 | 5.6% | EDGAR |
SC 13G/A | 2022-02-11 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Paratek Pharmaceuticals, Inc. | 2,239,937 | 4.3% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Paratek Pharmaceuticals, Inc. | 2,977,680 | 5.9% | EDGAR |
SC 13G | 2021-02-12 | HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. | Paratek Pharmaceuticals, Inc. | 90,020 | 0.2% | EDGAR |
SC 13G/A | 2021-02-09 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Paratek Pharmaceuticals, Inc. | 2,477,484 | 5.2% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | Paratek Pharmaceuticals, Inc. | 3,447,329 | 7.6% | EDGAR |
SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | Paratek Pharmaceuticals, Inc. | 1,258,000 | 3.8% | EDGAR |
SC 13G/A | 2020-02-14 | HIGHLAND CAPITAL MANAGEMENT LP | Paratek Pharmaceuticals, Inc. | 779,365 | 2.3% | EDGAR |
SC 13G/A | 2020-02-13 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Paratek Pharmaceuticals, Inc. | 2,378,931 | 6.7% | EDGAR |